Effect of risperidone in breath-holding

Efficacy of risperidone in the treatment of breath-holding attack in infants and children at neurology clinic of children’s medical center

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

IRCT

Registry ID

IRCT20200203046350N1

Enrollment

Registered

2020-12-12

Start date

2020-07-14

Completion date

Unknown

Last updated

2021-01-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

breath-holding. Other abnormalities of breathing

Interventions

Patients with a diagnosis of breath-holding attacks and over one year of age with a grade of two or three, treated with low-dose risperidone (one-quarter pill for children under two years of age and o

Eligibility

Sex/Gender

All

Age

1 Years to 7 Years

Inclusion criteria

Inclusion criteria: having experienced one or more breath-holding attack

Exclusion criteria

Exclusion criteria: Patients with a history of seizure

Design outcomes

Primary

Measure	Time frame
Number of breath-holding attack. Timepoint: Before treatment to three months after treatment. Method of measurement: Number of breath-holding attacks based on observation.;Breath holding grade. Timepoint: Before treatment to three months after treatment. Method of measurement: breath-holding grade based on observation.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactAlireza Abdi

Tehran University of Medical Sciences

Alireza.abdi129@gmail.com+98 21 6147 2751

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026